What? When? Why?

As per our research report, the global live cell imaging market was valued at USD 2.09 billion in 2022 and is anticipated to grow at a CAGR of 9.02% from 2022 to 2027.

Live cell imaging is a technique that provides real-time changes even in the subcellular events and helps optical studies of living cells over some time. It is a method of time using time-lapse microscopy and allows the cells to be monitored for a long time to visualize prolonged processes. It uses transmitted light and fluorescence microscopy to determine cell shape, motility, and position.

The outbreak began early in March 2020 and continued for over a year. Lockdowns and quarantines have been the result of the coronavirus outbreak. Many businesses have suffered losses due to shipping restrictions, and the unemployment rate has risen. Due to the unexpected increase in the number of patients and the severe shortage of hospital resources, such as staff, beds, and oxygen cylinders, the financial situation has deteriorated.

The COVID-19 pandemic has positively impacted the live cell imaging market since researchers could use live cell imaging tools to analyze cell behavior during virus research.

In addition, for generating vaccines, major live cell imaging system providers provided live cell imaging systems to COVID-19 researchers for biomedical research, which requires processing massive amounts of data. Moreover, the rising demand for early diagnosis and treatment of COVID-19 infection and to development of an effective vaccine has fueled the market's growth since it uses live cell imaging.

Growing adoption of live cell imaging by pharmaceutical companies, high-content screening techniques in drug discovery, and increasing demand for higher and faster diagnostic facilities are a few of the other factors driving the live cell imaging market. In addition, the increasing incidence of cancer, growing investments in R&D, rise in government funding for drug discovery in cells, growing demand for better and faster diagnostic facilities, and technological advancements are likely to drive the live cell imaging market.

Growing demand for various live cell imaging technologies and processes to augment growth.

The entire process of live cell imaging is cost-effective and swift, with high-content screening in the toxicity studies sector. Technological advancements help the machine improve the imaging of a live cell analyzer. However, researchers' most essential and helpful feature is its extraordinary ability to track and target live cells. Therefore, advancement in equipment technology would increase their usefulness. Additionally, increased live cell imaging in research by pharmaceutical companies to develop new drugs, efforts to develop innovative autonomous systems for high content detection, and its wide application area for studying dynamic processes are further presumed to augment the market growth.

Market players benefit from adopting high-content screening methods for primary screening, and its application for monitoring molecules in living animals is also presumed to drive market growth. Also, since cancer cases have been rising globally in recent years, there has been increasing demand for live cell imaging techniques.

On the other hand, the primary factor restraining the live cell imaging market includes the higher costs of these systems since advanced screening systems are updated with new features and thus are priced highly. Additionally, the maintenance costs and several indirect expenses are added to the expensive machinery, which further increases the overall cost of the system.

Moreover, handling the new technology requires many highly skilled professionals to study cell functions, and this lack of skilled professionals is also presumed to restrain the market's growth.

KEY FINDINGS OF THE REPORT:

Based on the product, the instruments segment is expected to retain a significant portion of the market since they operate independently without using other hardware. They help analyze and capture information regarding cell operations. To enable the most efficient collection of 3D imaging data, in vivo events have to be tracked in three-dimensional space by an update from Prior Scientific Instruments Ltd in October 2021. Therefore, Continuous technological advancements are further driving the adoption of the instruments. The consumables segment is expected to show the highest growth rate for the increased need for consumables, resulting in repeat purchases. There are several types, including glassware, plasticware, and general lab supplies.

Based on the application, the cell biology segment is anticipated to hold the largest share of the live cell imaging market since it has advanced lighting systems and filtering techniques, leading to a significant increase in research and molecular interactions. In addition, this technology provides spatial heterogeneity and superior clarity of structural components, further promoting its adoption. Furthermore, the stem cell biology segment is expected to grow at a healthy CAGR as it provides researchers with important information about stem cell behavior. For example, it helps them study their location, protein expression levels, differentiation status, and other functions.

Based on the end-user, the pharmaceutical and biotechnology companies segment is predicted to dominate the end-user segment because of their significant investments in research and development activities owing to the development of new drugs. Academic and Research institutes are also expected to dominate the segment owing to a rise in awareness and more significant investments in this field.

The North American live cell imaging market is expected to dominate worldwide during the forecast period. The main drivers in the region are a more extensive patient base, an increasing number of chronic diseases, substantial investments and funding for research purposes, an increasing number of R&D programs, and an expanding senior population. According to the Centers for Disease Control and Prevention, approximately 34,800 new HIV infections occurred in the United States in 2020. In addition, many patients and high disposable income are helping the government and research organizations. Due to the high rate of investment and robust technology infrastructure, tech-savvy research companies, large pharmaceutical and biotechnology companies, favorable regulations for drug development, and rapid adoption of advanced technologies are likely to drive the market in this region.

The Asia-Pacific live cell imaging market is expected to grow fastest, mainly due to many patients demanding effective and personalized medicines and significant government investments in research and development. In China, the growing demand for regenerative medicine research and an increase in government initiatives for stem cell therapy research is helping the region in the growth of the market.

The European live cell imaging market is expected to grow significantly due to factors such as a favorable regulatory environment, early adoption of the technology, and increased investments in regenerative medicine. In addition, the increasing prevalence of cancer and degenerative diseases, increased focus on the development of advanced live cell imaging techniques, increased investment in research and development activities, and the presence of well-developed research centers and facilities are some of the other factors that are expected to drive the market growth over the forecast period.

The regions of Latin America, the Middle East, and Africa are also expected to show significant growth in the market due to the increased use of stem cell research and advanced microscopy and the increase in the application of techniques in drug discovery and personalized medicine.

Nanolive SA, Bio-Rad Laboratories, KEYENCE Corporation, Sony Biotechnology, Inc., Phase Holographic Imaging PHI AB, Phase Focus Limited, CytoSMART Technologies, Etaluma, Inc., Oxford Instruments, and Thermo Fisher Scientific Inc. are some of the noteworthy players in the live cell imaging market.

RECENT MARKET DEVELOPMENTS:

In August 2022, MIT researchers developed a new way to make the invisible molecules visible by allowing molecules to unclamp through tissue before labeling the molecules. Thus, it makes the molecules more easily accessible in fluorescent labeling.

In June 2022, with a host of potential applications, Scientists at Trinity College Dublin created self-healing luminescent gels. Scientists could successfully introduce Guanosine into these gels from a life science perspective.